What's in Estudios Clínicos Latino América's pipeline?

Estudios Clínicos Latino América has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Estudios Clínicos Latino América's portfolio?

Top competitors by shared drug class: Hospital Universitari Vall d'Hebron Research Institute, Massachusetts General Hospital, S.L.A. Pharma AG.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/estudios-cl-nicos-latino-am-rica.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Estudios Clínicos Latino América — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Estudios Clínicos Latino América pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Icosapent ethyl (IPE)	Icosapent ethyl (IPE)	phase 3	Omega-3 fatty acid		Cardiovascular

Therapeutic area mix

Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Hospital Universitari Vall d'Hebron Research Institute · 1 shared drug class
Massachusetts General Hospital · 1 shared drug class
S.L.A. Pharma AG · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Estudios Clínicos Latino América:

Cite this brief

Drug Landscape (2026). Estudios Clínicos Latino América — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/estudios-cl-nicos-latino-am-rica. Accessed 2026-05-18.